These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 19207357

  • 21. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA, Schwartz RP, Jaffe JH, O'Grady KE.
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [Abstract] [Full Text] [Related]

  • 22. Breaking the habit: a retrospective analysis of desistance factors among formerly problematic heroin users.
    Best DW, Ghufran S, Day E, Ray R, Loaring J.
    Drug Alcohol Rev; 2008 Nov; 27(6):619-24. PubMed ID: 19023771
    [Abstract] [Full Text] [Related]

  • 23. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M, McIntosh J, McKeganey N, Robertson M.
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [Abstract] [Full Text] [Related]

  • 24. Changes in the use of medical services and prescription drugs among heroin users over two years.
    Darke S, Havard A, Ross J, Williamson A, Mills KL, Teesson M.
    Drug Alcohol Rev; 2007 Mar; 26(2):153-9. PubMed ID: 17364850
    [Abstract] [Full Text] [Related]

  • 25. VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population.
    Bargagli AM, Faggiano F, Amato L, Salamina G, Davoli M, Mathis F, Cuomo L, Schifano P, Burroni P, Perucci CA, VEdeTTE Study Group.
    Subst Use Misuse; 2006 Mar; 41(14):1861-79. PubMed ID: 17162594
    [Abstract] [Full Text] [Related]

  • 26. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 27. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U, Bonorden-Kleij K, Degkwitz P, Dilg C, Köhler WK, Passie T, Soyka M, Tanger S, Vogel M, Haasen C.
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [Abstract] [Full Text] [Related]

  • 28. Evidence for controlled heroin use? Low levels of negative health and social outcomes among non-treatment heroin users in Glasgow (Scotland).
    Shewan D, Dalgarno P.
    Br J Health Psychol; 2005 Feb; 10(Pt 1):33-48. PubMed ID: 15826332
    [Abstract] [Full Text] [Related]

  • 29. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study.
    Darke S, Williamson A, Ross J, Mills KL, Havard A, Teesson M.
    J Urban Health; 2007 Mar; 84(2):283-91. PubMed ID: 17265131
    [Abstract] [Full Text] [Related]

  • 30. A 10-year follow-up study on the health status of heroin addicts based on official registers.
    Sánchez-Carbonell X, Vilaregut A.
    Addiction; 2001 Dec; 96(12):1777-86. PubMed ID: 11784470
    [Abstract] [Full Text] [Related]

  • 31. Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study.
    Teesson M, Marel C, Darke S, Ross J, Slade T, Burns L, Lynskey M, Memedovic S, White J, Mills KL.
    Addiction; 2015 Jun; 110(6):986-93. PubMed ID: 25619110
    [Abstract] [Full Text] [Related]

  • 32. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.
    Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S.
    Drug Alcohol Depend; 2005 Jun 01; 78(3):309-15. PubMed ID: 15893162
    [Abstract] [Full Text] [Related]

  • 33. Recent life problems and non-fatal overdose among heroin users entering treatment.
    Neale J, Robertson M.
    Addiction; 2005 Feb 01; 100(2):168-75. PubMed ID: 15679746
    [Abstract] [Full Text] [Related]

  • 34. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R, Kelly E.
    Drug Alcohol Rev; 2007 Mar 01; 26(2):161-8. PubMed ID: 17364851
    [Abstract] [Full Text] [Related]

  • 35. The ageing heroin user: career length, clinical profile and outcomes across 36 months.
    Darke S, Mills KL, Ross J, Williamson A, Havard A, Teesson M.
    Drug Alcohol Rev; 2009 May 01; 28(3):243-9. PubMed ID: 19489991
    [Abstract] [Full Text] [Related]

  • 36. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.
    Encephale; 2009 Jun 01; 35(3):226-33. PubMed ID: 19540408
    [Abstract] [Full Text] [Related]

  • 37. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
    Darke S, Ross J, Lynskey M, Teesson M.
    Drug Alcohol Depend; 2004 Jan 07; 73(1):1-10. PubMed ID: 14687954
    [Abstract] [Full Text] [Related]

  • 38. The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment.
    Lejuez CW, Paulson A, Daughters SB, Bornovalova MA, Zvolensky MJ.
    Behav Res Ther; 2006 May 07; 44(5):667-77. PubMed ID: 16002042
    [Abstract] [Full Text] [Related]

  • 39. The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?
    Darke S, Ross J, Teesson M.
    Drug Alcohol Rev; 2007 Jan 07; 26(1):49-54. PubMed ID: 17364836
    [Abstract] [Full Text] [Related]

  • 40. Age differentials in the impacts of reduced heroin: effects of a "heroin shortage" in NSW, Australia.
    Degenhardt L, Day C, Conroy E, Gilmour S, Hall W.
    Drug Alcohol Depend; 2005 Sep 01; 79(3):397-404. PubMed ID: 15927418
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.